Democratic Congress May Mean Greater Postmarket Focus, FDA Funding

The rise of Reps. John Dingell (D-Mich.) and Henry Waxman (D-Calif.) to top committee positions as a result of the Democrats' takeover of the House in the Nov. 7 elections could mean more attention on device safety issues in the new Congress

More from Archive

More from Medtech Insight